Open AccessNovel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus
Author(s) -
Na Liu,
Wei Lei,
Huang Li,
F. Richard Yu,
Wei Xing Zheng,
Bingjie Qin,
Dongqin Zhu,
Susan L. MorrisNatschke,
Shibo Jiang,
Chin-Ho Chen,
KuoHsiung Lee,
Linghai Xie
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/50ct-kq06
Subject(s) - rilpivirine , reverse transcriptase , virology , nucleoside reverse transcriptase inhibitor , mutant , potency , reverse transcriptase inhibitor , wild type , human immunodeficiency virus (hiv) , chemistry , biology , in vitro , polymerase chain reaction , viral load , biochemistry , gene , antiretroviral therapy